Skip to main content
. 2008 Mar 12;99(5):1008–1015. doi: 10.1111/j.1349-7006.2008.00788.x

Figure 7.

Figure 7

In vivo antitumor effect of hsc70 fusion proteins against MO5 lung metastasis. (a) On day 0, mice were challenged with MO5 via the tail vein, and vaccinated with hsc70‐OVA257‐264 at days 0 and 7 (column 2) or at days 2 and 9 (column 3). The numbers of metastatic spots of the lung surface were counted on day 15 after sacrificing the mice. Control mice were not vaccinated (column 1) (n = 4 or 5). (b) Mice were immunized with hsc70‐OVA257‐264 (column 5) and OVA265‐280‐hsc70‐OVA257‐264 (column 6) at days 0, 2, 5, and 7, and the spot numbers of lungs, were counted at day 21. Control mice were not vaccinated (column 4) (n = 6).